Evidence map›Paper›PMID 42643984›Full record

ArticleEnvironment & health (Washington, D.C.)2026

Cotinine Promotes Cancer Cell Proliferation and m

Panlong Li, Xuyun Peng, Sihuang Wu, Jiani Wang, Yiju Huang, Zexiao Lin, Yang Yang, Weicheng Liang

Abstract read
In one paragraph

Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Panlong LiBiotherapy Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Xuyun PengBiotherapy Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Sihuang WuVaccine Research Institute, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Jiani WangBiotherapy Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Yiju HuangVaccine Research Institute, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Zexiao LinDepartment of Oncology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Yang YangDepartment of Spine Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Weicheng LiangBiotherapy Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.ORCID https://orcid.org/0000-0001-5425-5402

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotine is the most abundant alkaloid in tobacco, and 70%-80% of its metabolites are cotinine. In terms of that, numerous cigarettes are consumed worldwide, resulting in a large amount of cotinine being released into the environment and posing potential hazards. However, the biological effects of cotinine are poorly understood. In the current study, we identified that the oncogene Polo-like kinase 1 (PLK1) is a direct target of cotinine, and cotinine could upregulate the protein level of PLK1. Public epidemiological data indicated a positive correlation between PLK1 expression and smoking. Subsequent studies validated that PLK1 directly interacted with β-catenin, leading to transcriptional activation of tRNA methyltransferase 6 (TRMT6), a canonical methyltransferase involved in m

Indexed as

cotinineepigeneticslung cancerRNA methylationsmoke

Identifiers

PMID42643984
PMCPMC13504562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.